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Prevalence of  
Human Bocavirus 
in Human Tonsils 
and Adenoids
To the Editor: Recently, Longtin 
et al. (1) reported a high rate (43%) of 
human bocavirus (HBoV) infection in 
a group of children chosen to serve as 
controls in a study of HBoV preva-
lence among hospitalized children and 
adults. In contrast, previous reports 
had found low HBoV prevalence rates 
of 0%–1% in control groups (2,3). At-
tempting to explain this surprising dif-
ference in rates, Lu et al. (4) suggested 
that selection of control patients may 
be related to the difference in rates. 
The control group used in the Long-
tin study was primarily (71%) made 
up of children undergoing elective 
surgery; previous studies had selected 
control groups from other sources, in-
cluding well children on routine visits 
and outpatients with nonrespiratory 
symptoms. Because the Longtin study 
surgeries were mainly tonsillectomies, 
adenoidectomies, and myringotomies, 
Lu et al. examined the possibility that 
tonsillar tissues, which include the ad-
enoids, are sites of persistent HBoV 
infection. When these researchers ex-
tracted DNA from tonsillar lympho-
cytes obtained from pediatric patients 
who had undergone tonsillectomies or 
adenoidectomies, they detected HBoV 
DNA in 32% of the samples (4). These 
findings strongly suggest a connec-
tion between HBoV and tonsillar tis-
sue. Therefore, we tested a number of 
tonsillar samples for the presence of 
HBoV DNA.
Sample acquisition was approved 
by the Nationwide Children’s Hospi-
tal Institutional Review Board. Tonsils 
and adenoids were obtained from 91 
patients who underwent elective sur-
gery at Nationwide Children’s Hos-
pital from June through September 
2004. Patients’ ages ranged from 1 to 
16 years (median 5.9 years; age was 
unknown for 4 patients).
Samples consisted of surgically 
removed tonsil or adenoid tissues. 
DNA was extracted and its concentra-
tion was determined as previously de-
scribed (5). Two primer sets were used 
for HBoV detection by using real-time 
PCR with SYBR Green detection and 
melting-point determination. We de-
signed primers 3097F (5′-GTC-CAA-
TTA-CAT-GAT-CAC-GCC-TAC-TC) 
and 3420R (5′-TGC-GTC-CAC-AGT-
ATC-AGG-TTG-TTG) that targeted 
the viral protein 1/2 (VP1/VP2) region 
of HBoV. The nonstructural protein 
1 (NP1) region was targeted by us-
ing primers 188F and 542R from Al-
lander et al. (6) Each 20-μL reaction 
contained SYBR Green JumpStart Taq 
ReadyMix (Sigma, St. Louis, MO, 
USA), 4 mmol/L MgCl2, 250 nmol/L 
primers, double-distilled H2O, and 2 μL 
of DNA (50–200 ng) cycled on an ABI 
PRISM 7900HT (Applied Biosystems, 
Foster City, CA, USA) instrument at 
94oC for 2 min, followed by 40 cycles 
of 94°C for 20 s, 60°C (NP1 primers) 
or 68°C (VP1/VP2 primers) for 20 s, 
and 72°C for 14 s. Amplification and 
melting curves were analyzed with 
7900HT version 2.2.1 software (Ap-
plied Biosystems); positive samples 
were verified by sequence analysis. 
Sequenced VP- and NP1-generated 
amplicons were 99%–100% identical 
to HBoV strain ST1 (6). The detec-
tion sensitivities of the VP and NP1 
assays, determined by using a plasmid 
construct containing the full HBoV 
genome, were 1–5 and 5–10 gene cop-
ies/reaction, respectively.
Our testing identified HBoV 
DNA in 5 (5.5%) of the 91 children 
who underwent elective tonsillecto-
my/adenoidectomy. Ages ranged from 
1.9 to 4.6 years (median 3.4 years). 
The reason for the much lower HBoV 
prevalence in this group of children, 
compared with prevalences found in 
studies by Longtin et al. and Lu et al., 
is unclear. Lu et al. (4) reported a much 
higher HBoV rate of lymphocytes 
from adenoids (56%) than from ton-
sils (16%). Although we did not know 
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the exact tissue type of each sample, 
only that tonsils, adenoids, or both 
combined could be present, the 5.5% 
rate we found was about one third the 
rate found in tonsil lymphocytes and 
about one tenth the rate found in ad-
enoid lymphocytes.
A seasonal effect may contribute to 
the large discrepancies found in HBoV 
prevalences. Apparently, viruses can 
persist in tonsillar tissue well after the 
symptomatic phase of illness. In chil-
dren with no signs of acute respiratory 
infection, Drago et al. (7) reported that 
45.5% of samples contained viral nu-
cleic acid. Depending on the duration 
of persistence, asymptomatic children, 
sampled shortly after the season of the 
virus in question, would be more likely 
to have detectable virus in their tonsillar 
tissue. The Longtin et al. study samples 
were collected from December through 
April; our study samples were collected 
from June through September. If HBoV 
is seasonal, as has been suggested (3), it 
may have been circulating in the target 
population before samples were taken 
and persisted only in tonsillar tissues. 
Thus, if tonsillar tissue from asymp-
tomatic children was obtained within 
the persistence period after the HBoV 
season, samples would be HBoV posi-
tive; those obtained shortly after the 
persistence period would have a much 
lower rate.
Differences in patient age in the 
3 studies may also have contributed 
to the different rates observed. The 
Longtin et al. group was substantial-
ly younger (median age 23 months) 
than the Lu et al. group (median age 
5 years) or our group (median age 5.9 
years). Preliminary seroepidemiology 
reports indicate the presence of HBoV 
antibodies in >50% of children 2–3 
years of age (8,9).
The detection of HBoV in the 
tonsillar tissues we tested showed a 
higher rate of infection than would be 
expected in an asymptomatic popula-
tion. However, the rate was far lower 
than that previously reported for ton-
sillar tissues (1,4).  
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spp. in Fleas, Chile
To the Editor: Fleas are involved 
in the natural cycle of different Barto-
nella spp. Among the 20 currently rec-
ognized Bartonella spp., 13 species or 
subspecies have been implicated in hu-
man disease. Recently, B. rochalimae 
was identified in a patient who had re-
ceived numerous insect bites and sub-
sequently had bacteremia, fever, and 
splenomegaly after visiting Peru (1). 
A recent study in Taiwan suggested 
that rodents could be a reservoir for B. 
rochalimae (2), but the vector or other 
mechanism of infection remains un-
known. We amplified B. rochalimae, 
B. clarridgeiae, and B. henselae from 
fleas (Pulex irritans and Ctenocepha-
lides felis) collected in Chile and dis-
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